NIDA R21 grant awarded to Dr. Marsida Kallupi

A new R21 grant from the National Institute on Drug Abuse (NIDA) was awarded to Dr. Marsida Kallupi, with Dr. Abraham Palmer as co-investigator. 

The 2-year grant is titled “Enhancing Addiction Severity Prediction by Modulating GABAergic Activity in the Central Amygdala of RATTACA Rats” and it will start July 15, 2025 and end on June 30, 2027.

Congratulations!

Visualizing Genetic Contributions in N/NIH Heterogeneous Stock Rats

We use color coding to visually represent the genetic contributions of each founder strain in N/NIH heterogeneous stock (HS) rats. This method helps track the inheritance and distribution of alleles from the original strains throughout the HS population, providing clarity in genetic analysis. Each founder strain is assigned a distinct color to simplify genetic mapping. … Read more…

2025 pilot grants awarded

Congratulations to the 2025 Pilot Grants recipients: Caitlin A. Orsini, PhD (University of Texas at Austin).Project: Examination of behavioral vulnerability factors that confer risk to synthetic opioid use.

Manuscript accepted in PLOS Genetics

The manuscript titled “RatXcan: A framework for cross-species integration of genome-wide association and gene expression data” was accepted in PLOS Genetics.

Authors: Natasha Santhanam, Sandra Sanchez-Roige, Sabrina Mi, Yanyu Liang, Apurva S. Chitre, Daniel Munro, Denghui Chen, Riyan Cheng, Festus Nyasimi, Jianjun Gao, Anthony M. George, Alexander F. Gileta, Wenyan Han, Katie Holl, Alesa Hughson, Christopher P. King, Alexander C. Lamparelli, Connor D. Martin, Angel Garcia-Martinez, Celine L. St. Pierre, Sarah Sumner, Jordan Tripi, Tengfei Wang, Hao Chen, Shelly Flagel, Keita Ishiwari, Paul Meyer, Oksana Polesskaya, Laura Saba, Leah C. Solberg Woods, Abraham A. Palmer, Hae Kyung Im.

Congratulations!